PRTA

Prothena Corporation plc Ordinary Shares

$9.59 -5.80%

Recent alerts on PRTA

All signals →

Insider trade Purchase by SCULLY WILLIAM P

News FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy

News Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits

News Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?

News Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?

News The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)

News Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)

News Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod

News Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab

News Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance

News Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate

News Novo Nordisk gains Fast Track status for coramitug to treat ATTR amyloidosis

SEC filing PRTA Announces $100M Share Repurchase Plan for Outstanding Ordinary Shares

Scanner Unusual volume (z=10.7)

Scanner Unusual volume (z=10.9)

Scanner Unusual volume (z=10.9)

Scanner Unusual volume (z=10.9)

Get push alerts for PRTA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS